AHMED, SALAH, U,TSAO, JIAXIANG,MAHASHABDE, ANU,HARRISON, DIANE, D
申请号：
NZ58775809
公开号：
NZ587758A
申请日:
2009.02.03
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of: (a) a therapeutically effective amount of progesterone； (b) a polysiloxane elastomer； and (c) a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid in the preparation of a medicament for treating a luteal phase defect in a patient, wherein said medicament is a monolithic intravaginal ring comprising said therapeutically effective amount of progesterone, said polysiloxane elastomer and said pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid, and wherein the polysiloxane elastomer is present in a concentration of about 55% to about 90% by total weight of the ring.
